in this issue
People & Business :: M&A
India's foreign investment board clears Mylan's $1.6-billion acquisition of Agila
August 28, 2013 | Natasha Alperowicz
India’s Foreign Investment Promotion Board (New Delhi) has cleared Mylan's (Canonsburg, PA) proposal to acquire Agila Specialties (Bangalore, India), a subsidiary of pharma firm Strides Arcolab. Mylan on 27 February announced that it had signed a definitive agreement to acquire Agila, a developer, manufacturer, and marketer of generic injectable products, from Strides for approximately $1.6 billion in cash plus contingent payments of up to $250 million subject to conditions. Mylan says it has obtained $1 billion in committed financing, which...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee